Nkx-2.5 Regulates MDR1 Expression via Its Upstream Promoter in Breast Cancer Cells
10.3346/jkms.2019.34.e100
- Author:
Jung Suk LIM
1
;
Gyu Yeon JUNG
;
Seung Yoon PARK
Author Information
1. Department of Biochemistry, School of Medicine, Dongguk University, Gyeongju, Korea. psyoon@dongguk.ac.kr
- Publication Type:Original Article
- Keywords:
MDR1;
Nkx-2.5;
Transcriptional Regulation;
Breast Cancer
- MeSH:
Breast Neoplasms;
Breast;
Chromatin Immunoprecipitation;
Drug Resistance, Multiple;
Genes, Reporter;
Humans;
Immunoassay;
Immunoenzyme Techniques;
Phenotype;
Plasmids;
Real-Time Polymerase Chain Reaction;
RNA, Messenger;
Transcriptional Activation
- From:Journal of Korean Medical Science
2019;34(12):e100-
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Increased expression of MDR1 gene is one of the major mechanisms responsible for multidrug resistance in cancer cells. Two alternative promoters, upstream and downstream, are responsible for transcription of MDR1 gene in the human. However, the molecular mechanism regarding the transactivation of MDR1 upstream promoter (USP) has not been determined. METHODS: Dual-luciferase reporter gene assays were used to assess the effect of Nkx-2.5 on MDR1 USP activity using reporter plasmids for human MDR1 USP and its mutants. MDR1 mRNA level was examined by quantitative real-time PCR. The direct binding of Nkx-2.5 to the USP of MDR1 was evaluated by promoter enzyme immunoassays and chromatin immunoprecipitation assays.
